International conferences and seminars

08.07.2013

11th Vaccines Research & Development: All Things Considered

Dear Colleague,

GTC is proud to present its 11th Vaccines Research and Development: All Things Considered Conference, to be held in Boston, MA on July 8-10, 2013. As the name indicates, this conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions of the future of our discipline.

Development of new vaccines truly requires a consideration of many things. We examine vaccine development from basic research to marketing. We bring together the people who make the discoveries, make the decisions, fund the work and license the vaccines and foster their interaction with the attendees to share their perspectives of the vaccine industry. The latest information on the new malaria, HIV, tumor, and therapeutic vaccines, DNA vaccines, adjuvants, mucosal and other delivery mechanisms will be presented, as will updates on governmental priorities, funding, and the FDA. Representatives from the HHS, BARDA and NIH as well as NGO will provide a first-hand perspective into current US vaccines policy, regulation and funding as well as updates on the pandemic and bio-defense policy. All aspects from discovery to marketing will be covered.


The 11th Vaccines Research and Development: All Things Considered conference is part of our 3rd Infectious Diseases World Summit and will be held concurrently with two other tracks which are:

2nd Influenza Research & Development
10th Anti-Infectives Partnering & Deal-Making

Below are the sessions for the Vaccines conference:
Vaccines for the Developing World
Therapeutic, DNA & RNA Vaccines
Novel Technologies in Vaccine Development
Government Programs & Regulatory Policy
New Vaccines and Future Trends in Vaccine Discovery

Joint session (with 2nd Influenza Research & Development Conference):
Developments in the Universal Influenza Vaccine

We look forward to seeing you at the conference!

Sincerely,

2013 Vaccines Discovery and Development: All Things Considered Organizing Committee


Back to the list